Combining strategies to optimize a gel formulation containing miconazole: the influence of modified cyclodextrin on textural properties and drug release

Drug Development and Industrial Pharmacy

Volumn 36, Issue 6, 2010, Pages 705-714

  Ribeiro, Andreza Maria ^a   Figueiras, Ana ^b   Freire, Cristina ^b   Santos, Delfim ^a   Veiga, Francisco ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Carbopol; Gel; Methyl cyclodextrin; Miconazole; Pluronic; Textural properties

Indexed keywords

CARBOMER; METHYL BETA CYCLODEXTRIN; MICONAZOLE; POLOXAMER; POLYMER;

ADHESION; AQUEOUS SOLUTION; ARTICLE; CHEEK MUCOSA; COMPLEX FORMATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GEL; HUMAN; IN VITRO STUDY; THERMAL ANALYSIS; THERMOGRAPHY;

ADHESIVENESS; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; GELS; MEMBRANES, ARTIFICIAL; MICONAZOLE; SOLUBILITY;

EID: 77952499392     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903452260     Document Type: Article

References (57)

1. Peppas NA, Bures P, Leobandung W, Ichikawa H. (2000). Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm, 50 (1):27-46.
2. Brown AF, Jones DS, Woolfson AD, Irwin CR. (1997). Structural analysis of tetracycline gels for the treatment of periodontitis. J Dent Res, 76 (5):1156.
3. Jones DS, Woolfson AD, Brown AF. (1997). Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res, 14 (4):450-7.
4. Nagai T, Machida Y. (1993). Buccal delivery systems using hydrogels. Adv Drug Deliv Rev, 11 (1-2):179-91.
5. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. (2000). Practice guidelines for the treatment of candidiasis. Clin Infect Dis, 30 (4):662-78.
6. Shin SC, Kim JY, Oh IJ. (2000). Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Dev Ind Pharm, 26 (3):307-12.
7. Jones DS, Lawlor MS, Woolfson AD. (2002). Examination of the flow rheological and textural properties of polymer gels composed of poly (methylvinylether-co-maleic anhydride) and poly (vinylpyrrolidone): Rheological and mathematical interpretation of textural parameters. J Pharm Sci, 91 (9):2090-101.
8. Jacobsen J, Bjerregaard S, Pedersen M. (1999). Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity-drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur J Pharm Biopharm, 48 (3):217-24.
9. Saag MS, Dismukes WE. (1988). Azole antifungal agents- emphasis on new triazoles. Antimicrob Agents Chemother, 32 (1):1-8.
10. Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci, 85 (10):1017-25.
11. Loftsson T, Masson M. (2001). Cyclodextrins in topical drug formulations: Theory and practice. Int J Pharm, 225 (1-2):15-30.
12. Bilensoy E, Abdur Rouf M, Vural I, Šen M, Atilla Hincal A. (2006). Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-Cyclodextrin complex. AAPS PharmSciTech, 7(2):E54-60.
13. Bilensoy E, Rouf MA, Vural I, Hincal AA. (2006). Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin. J Control Release, 116 (2):e107-9.
14. Bilensoy E, Çirpanli Y, Şen M, Doǧan A, Çaliş S. (2007). Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: Cyclodextrin complex for HPV-induced cervical cancer. J Incl Phenom Macrocycl Chem, 57:363-70.
15. Kim EY, Gao ZG, Park JS, Li H, Han K. (2002). RhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm, 233 (1-2):159-67.
16. Qi H, Chen W, Huang C, Li L, Chen C, Li W, et al. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm, 337 (1-2):178-87.
17. Doliwa A, Santoyo S, Ygartua P. (2001). Transdermal iontophoresis and skin retention of piroxicam from gels containing piroxicam: Hydroxypropyl-beta- cyclodextrin complexes. Drug Dev Ind Pharm, 27 (8):751-8.
18. Ribeiro A, Figueiras A, Santos D, Veiga F. (2008). Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-β-cyclodextrin. AAPS Pharm- SciTech, 9 (4):1102-9.
19. Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. (2005). Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Control Release, 102 (1):159-69.
20. Jun. SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, et al. (2007). Preparation and characterization of simvastatin/hydroxypropylbeta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm, 66 (3):413-21.
21. Cavrini V, Pietra MD, Gatti R. (1989). Analysis of miconazole and econazole in pharmaceutical formulations by derivative UV spectroscopy and liquid chromatography (HPLC). J Pharm Biomed Anal, 7:1535-43.
22. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res, 23 (12):2709-28.
23. das Neves J, Bahia MF. (2006). Gels as vaginal drug delivery systems. Int J Pharm, 318 (1-2):1-14.
24. Tunick MH. (2000). Rheology of dairy foods that gel, stretch, and fracture. J Dairy Sci, 83 (8):1892-8.
25. Sandhu KS, Singh N. (2007). Some properties of corn starches II: Physicochemical, gelatinization, retrogradation, pasting and gel textural properties. Food Chem, 101 (4):1499-507.
26. Tan Y, Peh K, Al-Hanbali O. (2000). Effect of carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels. AAPS PharmSciTech, 1 (3):69-78.
27. Kim EY, Gao ZG, Park JS, Li H, Han K. (2002). RhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm, 233 (1-2):159-67.
28. Escobar-Chávez JJ, López-Cervantes M, Naïk A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. (2006). Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci, 9 (3):339-58.
29. Delgado MI, Cucala J, Obach R. (1994). Validation of an automated sampling system with Franz diffusion cells. Drug Dev Ind Pharm, 20 (14):2267-83.
30. Fitzpatrick D, Corish J. (2006). Release characteristics of anionic drug compounds from liquid crystalline gels: III. Chemical and iontophoretic enhancement of delivery across non-rate-limiting membranes. Int J Pharm, 325 (1-2):90-8. (Pubitemid 44573705)
31. Corbo M, Schultz TW, Wong GK, Buskirk GAV. (1993). Development and validation of in vitro release testing methods for semisolid formulations. Pharm Technol, 17 (9):112-28.
32. Toscano C, Campos R, Bica A, Farinha AR. (2001). Desenvolvimento e validação de um sistema de avaliação da liberação invitro do peróxido de benzoíla veiculado em géis. Braz J Pharm Sci, 37 (3):341-6.
33. Ventura CA, Tommasini S, Falcone A, Giannone I, Paolino D, Sdrafkakis V, et al. (2006). Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm, 314 (1):37-45.
34. Montenegro L, Carbone C, Paolino D, Drago R, Stancampiano AH, Puglisi G. (2008). In vitro skin permeation of sunscreen agents from O/W emulsions. Int J Cosmetic Sci, 30 (1):57-65.
35. Touitou E. 2004. Compositions for applying active substances to or through the skin. Jerusalem patent EP0804160.
36. FDA. (1997). Food and Drug Administration Center for Drug Evaluation and Reserch (CDER) Guindance for industry: Dissolution testing of immediate release solid oral dosage forms. Rockville, IN: FDA.
37. O'Hara T, Dunne A, Butler J, Devane J. (1998). A review of methods used to compare dissolution profile data. Pharm Sci Technol Today, 1 (5):214-23.
38. Koester LS, Ortega GG, Mayorga P, Bassani VL. (2004). Mathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to beta-cyclodextrin. Eur J Pharm Biopharm, 58 (1):177-9.
39. Piel G, Evrard B, Fillet M, Llabres G, Delattre L. (1998). Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int J Pharm, 169 (1):15-22.
40. Tenjarla S, Puranajoti P, Kasina R, Mandal T. (1998). Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. J Pharm Sci, 87 (4):425-9.
41. Piel G, Evrard B, Van Hees T, Delattre L. (1999). Comparison of the IV pharmacokinetics in sheep of miconazole-cyclodextrin solutions and a micellar solution. Int J Pharm, 180 (1):41-5.
42. Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB. (2007). Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Eur J Pharm Biopharm, 67 (2):531-9.
43. Loftsson T, Brewster M, Masson M. (2004). Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv, 2:1-14.
44. Barreiro-Iglesias R, Alvarez-Lorenzo C, Concheiro A. (2002). Thermal and FTIR characterization of films obtained from carbopol/surfactant aqueous solutions. J Therm Anal Calorim, 68 (2):479-88.
45. Kanis LA, Viel FC, Crespo JS, Bertolino JR, Pires ATN, Soldi V. (2000). Study of poly (ethylene oxide)/Carbopol blends through thermal analysis and infrared spectroscopy. Polymer, 41 (9):3303-9.
46. Singla AK, Chawla M, Singh A. (2000). Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm, 26 (9):913-24.
47. Boulmedarat L, Grossiord JL, Fattal E, Bochot A. (2003). Influence of methyl-beta-cyclodextrin and liposomes on rheological properties of Carbopol (R) 974P NF gels. Int J Pharm, 254 (1):59-64.
48. Qi HY, Li L, Huang CY, Li WM, Wu CJ. (2006). Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use. Chem Pharmaceut Bull, 54 (11):1500-7.
49. Bonacucina G, Spina M, Misici-Falzi M, Cespi M, Pucciarelli S, Angeletti M, et al. (2007). Effect of hydroxypropyl beta-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407. Eur J Pharm Sci, 32 (2):115-22.
50. Park KM, Bae JW, Joung YK, Shin JW, Park KD. (2008). Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Colloids Surf B, 63 (1):1-6.
51. ® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release, 82 (2-3):189-212.
52. Franz TJ. (1975). Percutaneous absorption-relevance of in vitro data. J Invest Dermatol, 64 (3):190-5.
53. Higuchi T. (1963). Mechanism of sustained-action medication- theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52 (12):1145.
54. Higuchi WI. (1962). Analysis of data on medicament release from ointments. J Pharm Sci, 51 (8):802-4.
55. Higuchi WI, Higuchi T. (1960). Theoretical analysis of diffusional movement through heterogeneous barriers. J Am Pharm Assoc, 49 (9):598-606.
56. Khan KA. (1975). Concept of dissolution efficiency. J Pharm Pharmacol, 27 (1):48-9.
57. Anderson NH, Bauer M, Boussac N, Khan-Malek R, Munden P, Sardaro M. (1998). An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed, 17 (4-5):811-22.